Are high doses of insulin correlated with markers of metabolic stress in patients with type 2 diabetes?
Not Applicable
Completed
- Conditions
- type 2 diabetesMetabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12616001542482
- Lead Sponsor
- Cornelia Bala
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
1.adult (>=18 years) patients with type 2 diabetes, treated with insulin for at least 6 months;
2.stable insulin dose (+/- 10%) in the last 3 months;
3.patients who signed informed consent.
Exclusion Criteria
type 1 and other specific types of diabetes including gestational diabetes; diabetic ketoacidosis and hyperglycemic-hyperosmolar state; acute illnesses able to influence current insulin doses; acute infections; ALAT and/or ALAT>3 ori upper normal limit, eGFR<30 ml/min/1,73 m2); antiinflammatory drugs, except aspirin<300 mg/day within the previous 3 months; pregnancy and lactation
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method